New Delhi, India: India’s Production Linked Incentive (PLI) Schemes have attracted more than ₹2.40 lakh crore in investments and generated over 14.15 lakh jobs as of March 31, 2026, while driving exports worth over ₹15.2 lakh crore, according to information shared by the Ministry of Commerce and Industry.
The Government’s Production Linked Incentive (PLI) programme continues to strengthen India’s manufacturing landscape, with cumulative investments crossing ₹2.40 lakh crore and employment generation exceeding 14.15 lakh people across 14 key sectors by the end of FY 2025-26.
According to the Ministry of Commerce and Industry, actual investments under the schemes reached ₹2,40,138 crore as of March 31, 2026. The initiatives have also helped generate 14.15 lakh jobs, including 8,49,069 direct jobs and 5.66 lakh indirect jobs reported under the Large Scale Electronics Manufacturing, IT Hardware and High Efficiency Solar PV Modules sectors.
Exports supported under the PLI programme have also grown sharply over the past three financial years. Cumulative exports increased from ₹4.0 lakh crore in FY 2023-24 to ₹6.5 lakh crore in FY 2024-25, before reaching ₹15.2 lakh crore in FY 2025-26.
Several sectors have recorded notable progress under the programme. Mobile phone production has increased by around 2.4 times since the launch of the Large Scale Electronics Manufacturing scheme, while imports have declined by about 77%. Around 99.2% of mobile phones used in India are now manufactured domestically.
The pharmaceutical sector has reported cumulative sales of over ₹3.64 lakh crore under the scheme, supporting domestic production of 1,931 pharmaceutical products, including 191 bulk drugs. In the bulk drugs segment, manufacturing capacity of nearly 55,000 metric tonnes has been established across 26 critical Active Pharmaceutical Ingredients (APIs).
The medical devices sector has facilitated domestic production of advanced equipment such as CT scanners, MRI systems, cath labs and ultrasound equipment. Meanwhile, 22 applicants have begun operations and 55 indigenous medical device projects have been commissioned.
The government said implementation of the PLI schemes is regularly reviewed by the Empowered Group of Secretaries (EGoS), while periodic policy refinements, stakeholder consultations and faster issue resolution are being undertaken to improve scheme implementation, accelerate investments and strengthen India’s manufacturing competitiveness.
Source: This article is based on an official press release issued by the Press Information Bureau, Ministry of Commerce & Industry, Government of India
Press Release Page | Press Information Bureau
